Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145972 | SCV000193118 | pathogenic | Weaver syndrome | 2014-04-09 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000145972 | SCV002579297 | pathogenic | Weaver syndrome | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Cincinnati Center for Growth Disorders, |
RCV000145972 | SCV000588200 | pathogenic | Weaver syndrome | no assertion criteria provided | research | This is a de novo variant in EZH2. The patient's phenotype fits perfectly with Weaver Syndrome with tall stature and advanced bone age. This same variant is already in ClinVar in another patient with Weaver Syndrome. | |
Genome |
RCV001249312 | SCV001423275 | not provided | EZH2-related disorder | no assertion provided | phenotyping only | Variant interpretted as Pathogenic and reported on 12-04-2018 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |